
Castle Biosciences CSTL
€ 19.72
-0.35%
Quartalsbericht 2025-Q3
hinzugefügt 03.11.2025
Castle Biosciences EV 2011-2026 | CSTL
EV Jährlich Castle Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 665 M | 619 M | 586 M | 799 M | 879 M | 194 M | 28 M | 24.1 M | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 879 M | 24.1 M | 474 M |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
45.8 B | $ 115.19 | 0.1 % | $ 35 B | ||
|
BioNano Genomics
BNGO
|
34.1 M | $ 1.14 | 0.44 % | $ 6.21 M | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 16.2 | 0.56 % | $ 174 M | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 16.29 | 1.46 % | $ 868 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 1.41 | 2.92 % | $ 1.88 M | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 2.25 | -2.17 % | $ 9.95 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 175.38 | -0.17 % | $ 8.69 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
14 B | $ 498.64 | 1.04 % | $ 14.4 B | ||
|
Danaher Corporation
DHR
|
145 B | $ 190.7 | 0.6 % | $ 136 B | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.47 | 2.64 % | $ 414 M | ||
|
Illumina
ILMN
|
15.3 B | $ 122.51 | 1.3 % | $ 19.5 B | ||
|
NeoGenomics
NEO
|
1.85 B | $ 7.94 | 3.19 % | $ 1.02 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 14.95 | 3.57 % | $ 452 M | ||
|
Guardant Health
GH
|
15.2 B | $ 78.76 | 0.2 % | $ 9.87 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
990 K | $ 2.77 | 2.97 % | $ 89.9 K | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.07 | -3.19 % | $ 4.75 M | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
13.2 B | $ 28.27 | -0.12 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 107.75 | 0.88 % | $ 8.89 B | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 261.97 | 0.4 % | $ 21.8 B | ||
|
Natera
NTRA
|
5.53 B | $ 199.83 | 3.52 % | $ 19.7 B | ||
|
Celcuity
CELC
|
5.57 B | $ 118.95 | 1.55 % | $ 5.56 B | ||
|
Senseonics Holdings
SENS
|
376 M | $ 6.67 | -0.15 % | $ 278 M | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 80.99 | 0.5 % | $ 5.47 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 192.07 | 0.29 % | $ 21.3 B | ||
|
Soleno Therapeutics
SLNO
|
2.13 B | $ 52.58 | -0.1 % | $ 2.67 B | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 9.19 | -2.46 % | $ 1.99 B | ||
|
ENDRA Life Sciences
NDRA
|
4.49 M | $ 5.0 | 1.21 % | $ 3.94 M | ||
|
Organovo Holdings
ONVO
|
-4.05 M | - | -2.3 % | $ 19.4 M |